Patents by Inventor Frits VAN RHEE

Frits VAN RHEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF AUTOLOGOUS EFFECTOR CELLS AND ANTIBODIES FOR TREATMENT OF MULTIPLE MYELOMA
    Publication number: 20130058921
    Abstract: The present disclosure provides methods for treating multiple myeloma using a combination of autologous expanded and activated NK cells from the patient and an antibody that targets an antigen on myeloma cells and/or an antibody that targets the KIR antigen on NK cells, wherein the antibodies elicit ADCC toward myeloma cells. The present disclosure provides methods for treating multiple myeloma using a combination of autologous NK cells and the anti-CS1 antibody elotuzumab.
    Type: Application
    Filed: October 30, 2009
    Publication date: March 7, 2013
    Inventor: Frits Van Rhee
  • USE OF AUTOLOGOUS EFFECTOR CELLS FOR TREATMENT OF MULTIPLE MYELOMA
    Publication number: 20130052158
    Abstract: The present disclosure provides methods for treating multiple myeloma using autologous expanded and activated NK cells.
    Type: Application
    Filed: October 30, 2009
    Publication date: February 28, 2013
    Applicant: University of Arkansas for Medical Science
    Inventor: Frits Van Rhee
  • USE OF ALLOGENEIC EFFECTOR CELLS AND ANTI-CS1 ANTIBODIES FOR SELECTIVE KILLING OF MULTIPLE MYELOMA CELLS
    Publication number: 20080095768
    Abstract: Methods for treating MM using anti-CS1 antibodies are provided herein.
    Type: Application
    Filed: August 7, 2007
    Publication date: April 24, 2008
    Applicants: PDL BIOPHARMA, INC., UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCE
    Inventors: Daniel AFAR, Frits VAN RHEE